In this episode of ATTD 2025 Conference Catch-Up, we dive into Toward the Cure of Type 1 Diabetes, featuring exciting discussions on cutting-edge strategies, from gene therapy to biomaterials, aimed at advancing beta cell replacement and ultimately finding a cure for type 1 diabetes.

Join us as we summarize key takeaways from these thought-provoking presentations:

• Biomaterials to Aid Beta Cell Replacement - Current and Future Perspectives – Dr. Victoria Salem
• New Strategies for Curative Therapies for Diabetes – Prof. Stefan Bornstein
• Update on Efforts to Interdict Type 1 Diabetes – Dr. Desmond Schatz

This episode is an essential listen for endocrinologists, diabetes researchers, clinicians, and healthcare professionals interested in the latest advances in curative therapies, including gene therapy, biomaterials, and novel treatments aimed at reversing type 1 diabetes.

Enjoy the listen!

This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.

ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.

https://attd.kenes.com

In this episode of ATTD 2025 Conference Catch-Up, we dive into View, Counterview: Time in Tight Range Should Be the Primary Treatment Goals and Outcome Measure in Diabetes, featuring a lively debate on the role of time in tight range as a primary treatment goal, weighing the benefits of advanced CGM technology against the potential psychological and practical challenges.

Join us as we summarize key takeaways from these thought-provoking presentations:

• View – Dr. Anders Carlson
• Counterview – Dr. Jeremy Pettus
• Rebuttal by Speaker Presenting View – Dr. Anders Carlson
• Rebuttal by Speaker Presenting Counterview – Dr. Jeremy Pettus

This episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals looking to explore the role of tight glycemic control in diabetes management, understand the advantages and challenges of using time in range as an outcome measure, and gain insight into the evolving landscape of diabetes care.

Enjoy the listen!

This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.

ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.

https://attd.kenes.com

In this episode of ATTD 2025 Conference Catch-Up, we dive into Time in Tight Glycemic Range: A Crucial Goal or an Unnecessary Burden?, featuring an in-depth exploration of the complexities behind glycemic control, the challenges of achieving tight ranges, and the need for personalized, accessible diabetes management strategies. 

Join us as we summarize key takeaways from these thought-provoking presentations: 

• Time in Tight Glycemic Range: Overview of the Physiological Data – Dr. Anders Carlson 
• Qualitative Data Perspective – Dr. Molly Tanenbaum 
• Health Inequalities Perspective – Dr. David Kerr 
• PwD Perspective – Ms. Julie Heverly 

This episode is an essential listen for endocrinologists, diabetes specialists, healthcare providers, and researchers looking to understand the physiological, social, and practical complexities of achieving tight glycemic control and how to better support personalized diabetes management. 

Enjoy the listen! 

This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  

ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com 

In this episode of ATTD 2025 Conference Catch-Up, we dive into Closed-Loop Control Systems: Advancements and Applications, featuring breakthrough discussions on the latest closed-loop systems, their impact on glycemic control, and the ongoing advancements aimed at improving accessibility and outcomes for individuals with type 1 diabetes. 

Join us as we summarize key takeaways from these thought-provoking presentations: 

• Closed-loop from Diagnosis: What Have We Learned from the Longest-Ever Closed-Loop Study - Dr. Charlotte Boughton 

• NAP @ Home: First Outpatient Studies of Neural-net Artificial Pancreas -Dr. Laya Ekhlaspour 

• Cam APS FX in Very Young Children in Italy; 2-Year Follow-Up - Prof. Marco Marigliano 

• How Do I See the Future of AID? - Prof. Roman Hovorka 

This episode is an essential listen for healthcare professionals and researchers in the field of diabetes care, looking to stay updated on the latest advancements in closed-loop insulin delivery systems, as well as their future potential for improving glycemic control and quality of life for patients with type 1 diabetes. 

Enjoy the listen!

This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  

ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com 

In this episode of ATTD 2025 Conference Catch-Up, we dive into the ATTD Yearbook Session, featuring a dynamic review of the year’s most impactful advances in diabetes technology, therapies, and care delivery—from AI-driven insulin systems to digital health, telemedicine, and emerging treatments across all ages and care settings. 

Join us as we summarize key takeaways from these thought-provoking presentations: 

• Virtual Clinics for Diabetes Care – Prof. Satish Garg 
• Continuous and Intermittent Glucose Monitoring in 2024 – Dr. Klemen Dovč 
• Insulin Delivery Hardware: Pumps and Pens – Dr. Rayhan Lal
• New Insulins, Biosimilars and Insulin Therapy – Dr. Torben Biester 
• Closed-Loop, Artificial Intelligence-Based Decision Support Systems and Data Science – Prof. Revital Nimri 
• Using Digital Health Technology to Prevent and Treat Diabetes – Dr. Neal Kaufman 
• Technology and Pregnancy – Prof. Helen Murphy 
• Diabetes Technology and Therapy in the Pediatric Age Group – Dr. David Maahs 
• Advances in Exercise and Nutrition as Therapy in Diabetes – Dr. Dessi Zaharieva 
• Primary Care and Diabetes Technologies and Treatments – Dr. Gregg Simonson 
• Use of Technologies at the Advanced Age – Prof. Tali Cukierman-Yaffe 
• Diabetes Technology in the “Real World”: Expanding Access and Addressing Disparities – Dr. Stuart Weinzimer 
• Diabetes Technology in the Hospital – Dr. Francisco Pasquel 
• Diabetes Technology and the Human Factor – Dr. Alon Liberman 
• Immune Interventions and Restorative Therapies in Type 1 Diabetes – Dr. Laura Jacobsen 
• New Medications for the Treatment of Diabetes – Prof. Irl Hirsch 
• Obesity and Diabetes – Prof. Viral Shah 
• Emerging Trends in MAFLD and MASH – Dr. Samita Garg 

This episode is an essential listen for diabetes clinicians, researchers, digital health innovators, and healthcare leaders looking to stay informed on the biggest developments of the past year in diabetes care—across clinical practice, digital transformation, and therapeutic innovation. 

Enjoy the listen! 

This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  

ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com

In this episode of ATTD Conference Catch-Up, we dive into Pediatric Obesity: Current Challenges and Future Directions, featuring a comprehensive look at the genetic, environmental, and therapeutic factors shaping the future of pediatric obesity management.

Join us as we summarize key takeaways from these thought-provoking presentations:

• A Holistic Approach to Understanding Childhood Obesity – Prof. Antje Körner
• Advances in Pharmacological Interventions for Pediatric and Adolescent Obesity – Current Status and Future Prospects – Dr. Jamie Matu
• Therapy for Monogenic Obesity – Prof. Primož Kotnik

This episode is an essential listen for pediatric endocrinologists, obesity specialists, diabetes care teams, and healthcare professionals working with children and adolescents, looking to understand the latest science and strategies to combat pediatric obesity—ranging from individualized treatment for monogenic obesity to emerging pharmacological therapies and multidisciplinary care approaches.

Enjoy the listen!

This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.

ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19–22, 2025, in Amsterdam. https://attd.kenes.com

In this episode of ATTD 2025 Conference Catch-Up, we dive into Artificial Intelligence (AI) Technology for Diabetes, featuring explorations of AI's role in predicting complications, enhancing automated insulin delivery, and advancing personalized diabetes management. 

Join us as we summarize key takeaways from these thought-provoking presentations: 

• Machine Learning Methods Predicting Diabetes Complications – Dr. Riccardo Bellazzi 
• Applications of Generative AI to Diabetes – Prof. Josep Vehi 
• AI-Enabled Meal Detection and Dosing in Automated Insulin Delivery Systems – Dr. Peter Jacobs 
• AI Takes Diabetes Management Beyond AID – Dr. Deborah Wake 

This episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals keen on harnessing AI technologies for improving diabetes care, from predicting complications to optimizing automated insulin delivery and personalizing treatment plans. 

Enjoy the listen! 

This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  

ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com

In this episode of ATTD 2025 Conference Catch-Up, we dive into Continuous Glucose Monitoring (CGM) in Type 2 Diabetes, featuring discussions on the impact of CGM on glycemic control, cost-effectiveness, and its integration with lifestyle interventions and medications for improved diabetes management. 

Join us as we summarize key takeaways from these thought-provoking presentations: 

• Real World Data on CGM in Type 2 Diabetes - Glucose Control Improvement – Dr. Richard Bergenstal 
• Glycemic Excursion Minimization (GEM): A Lifestyle Intervention for the Management of Type 2 Diabetes – Prof. Chiara Fabris 

• Cost Benefits of CGM Use in Type 2 Diabetes – Dr. Roy Beck 

• CGM-Based Intensification and De-Intensification of Therapy in Type 2 Diabetes – Prof. Irl Hirsch 

This episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals focused on Type 2 diabetes management, looking to learn more about the role of CGM in optimizing treatment plans, improving glycemic control, and managing healthcare costs. 

Enjoy the listen! 

This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  

ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com

In this episode of ATTD 2025 Conference Catch-Up, we dive into Obesity and Type 1 Diabetes: Tailoring Treatment, featuring insights on the prevalence, pharmacotherapy, and lifestyle strategies for managing obesity in individuals with Type 1 diabetes. 

Join us as we summarize key takeaways from these thought-provoking presentations: 

• Prevalence of Obesity in Type 1 Diabetes – Prof. Shlomit Shalitin 
• Newer GLP Analogs for Treatment of Obesity in Type 1 Diabetes – Prof. Satish Garg 
• Use of GLP1 Analogs in Youth with Type 1 Diabetes for Weight Management in Youth – Dr. Lori Laffel 
• Changing Behaviors to Manage Weight in Children and Adolescents with Type 1 Diabetes – Dr. Carmel Smart 

This episode is an essential listen for endocrinologists, pediatricians, diabetes specialists, and healthcare professionals focusing on the intersection of obesity management and Type 1 diabetes, seeking to optimize treatment strategies for this complex condition. 

Enjoy the listen! 

This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  

ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com

In this episode of ATTD 2025 Conference Catch-Up, we dive into Digital Twins and Artificial Intelligence, featuring cutting-edge applications of digital twins and AI to simulate patient-specific scenarios and optimize personalized treatment strategies in diabetes care. 

Join us as we summarize key takeaways from these thought-provoking presentations: 

• Creating Digital Twins: Model-Driven and AI Methods – An Introduction – Prof. Giacomo Cappon 
• How Digital Twins Can Enhance Clinical Trials – Prof. Boris Kovatchev 
• Digital Twins, Replay Simulation, and Decision Support – Prof. Anas El Fathi 
• AI Analytics and CGM Data Science – Dr. Clara Mosquera-Lopez 

This episode is an essential listen for endocrinologists, diabetes researchers, AI specialists, and healthcare professionals looking to stay ahead of the curve in using AI and digital twin technologies for personalized diabetes management and treatment optimization. 

Enjoy the listen! 

This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  

ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com

In this episode of ATTD 2025 Conference Catch-Up, we dive into Adult Obesity: Causes, Risks, and Management Strategies, featuring insights on the SELECT trial, GLP-1 receptor agonists, and innovative approaches to managing obesity, Type 2 diabetes, and metabolic liver diseases. 

Join us as we summarize key takeaways from these thought-provoking presentations: 

• Lessons from the SELECT Trial: Rethinking the Clinical Applications for the GLP-1RA Semaglutide – Prof. Donna Ryan 
• Heterogeneity of Obesity and Type 2 Diabetes – Prof. Ewan Pearson 
• Incretin-Based Therapies for the Treatment of Obesity-Related Diseases – Prof. Francesco Giorgino 
• Prevalence and Rationale for New Terminologies in NAFLD – Dr. Samita Garg 

This episode is an essential listen for endocrinologists, diabetes specialists, obesity researchers, and healthcare professionals looking to stay informed about the latest therapeutic strategies for managing obesity and metabolic diseases, with a focus on clinical applications and emerging terminologies. 

Enjoy the listen! 

This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  

ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com

In this episode of ATTD 2025 Conference Catch-Up, we dive into Beta Cell Therapies for Type 1 Diabetes, featuring innovative discussions on regenerative therapies, stem cell approaches, and novel treatments to protect and regenerate beta cells in the fight against Type 1 diabetes. 

Join us as we summarize key takeaways from these thought-provoking presentations: 

• Human Beta Cell Regenerative Drug Therapy: A Journey from Impossible to Possible – Dr. Andrew Stewart 
• Optimizing Differentiation and Engraftment of Stem Cell-Derived Islets for Type 1 Diabetes Treatment – Dr. Maria Cristina Nostro 
• Optimizing Stem Cell-Derived Beta Cell Function for Transplantation – Prof. Matthias Hebrok 
• Novel Type 1 Diabetes Therapies Targeting Endogenous Islet Cells – Prof. Anath Shalev 

This episode is an essential listen for endocrinologists, diabetes researchers, stem cell scientists, and healthcare professionals looking to stay on top of the latest advancements in beta cell regeneration and transplantation therapies for Type 1 diabetes. 

Enjoy the listen! 

This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  

ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com

In this episode of ATTD 2025 Conference Catch-Up, we dive into Debate: Is There a Real Unmet Need for Continuous Ketone Monitoring?, featuring a compelling discussion on the potential benefits and challenges of continuous ketone monitoring, exploring its role in preventing diabetic ketoacidosis and its place in diabetes management.

Join us as we summarize key takeaways from these thought-provoking presentations:

• View – Prof. Jennifer Sherr
• Counterview – Dr. Steven Edelman
• Rebuttal by Speaker Presenting View – Prof. Jennifer Sherr
• Rebuttal by Speaker Presenting Counterview – Dr. Steven Edelman

This episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals looking to understand the potential clinical impact of continuous ketone monitoring in diabetes management, its role in preventing complications, and its future integration into patient care.

Enjoy the listen!

This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.

ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.

https://attd.kenes.com

In this episode of ATTD 2025 Conference Catch-Up, we dive into Early Detection: Innovative Technologies for Type 1 Diabetes Diagnosis, featuring groundbreaking discussions on population-level screening, antibody detection, and strategies to implement early detection of Type 1 diabetes globally. 

Join us as we summarize key takeaways from these thought-provoking presentations: 

• General Population Screening – Successes and Pitfalls – Dr. Anastasia Albanese-O’Neill 
• Update on ADIR (Antibody Detection Israeli Research) Project – Prof. Moshe Phillip & Dr. Tal Oron 
• Screening of Type 1 Diabetes and Celiac Disease of the General Pediatric Population in Italy: Progress and Preliminary Results – Prof. Emanuele Bosi 
• EDENT1FI: Toward General Population Screening in Europe – Prof. Chantal Mathieu 

This episode is an essential listen for endocrinologists, diabetes researchers, public health professionals, and anyone involved in diabetes prevention, looking to stay updated on the latest advancements in early diagnosis and screening strategies. 

Enjoy the listen! 

This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  

ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com

In this episode of ATTD 2025 Conference Catch-Up, we dive into CGM as a Potential Diagnostic Tool, featuring insights on the evolving role of Continuous Glucose Monitoring (CGM) in diagnosing and managing both Type 1 and Type 2 diabetes, with a focus on early detection and precision medicine. 

Join us as we summarize key takeaways from these thought-provoking presentations: 

• Precision Medicine in Stage 2 Type 1 Diabetes – Prof. Chantal Mathieu 
• Data-Driven Approaches in Endocrinology: From CGM to Omics Data – Dr. Smadar Shilo 
• Consensus on the Use of CGM in Individuals with Type 2 Diabetes – Prof. Tadej Battelino 

This episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals looking to stay on top of the latest advancements in CGM technologies and their role in early diabetes diagnosis and management. 

Enjoy the listen! 

This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  

ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com

In this episode of ATTD Conference Catch-Up, we dive into Elevating Early Careers: Insights, Skills, and Strategies, featuring expert insights on career development, mentorship, and effective communication for early-career professionals in diabetes and endocrinology.

Join us as we summarize key takeaways from these thought-provoking presentations:

• Career Planning, Goal-Setting, and Networking Strategies – Prof. Olga Kordonouri
• Insights into Manuscript Writing – Dr. Steven Kahn
• Skills for Presenting Research to Diverse Audiences – Prof. Partha Kar

This episode is an essential listen for early-career researchers, clinicians, and healthcare professionals in diabetes, looking to refine their career strategies, improve research writing, and enhance presentation skills.

Enjoy the listen!

This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.

ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.

https://attd.kenes.com  

In this episode of ATTD Conference Catch-Up, we dive into the hot topics planned for discussion at ATTD 2025. Get ready for an exciting preview of the latest advancements and cutting-edge research that will shape the future of diabetes care.

From innovative technologies and treatments to breakthroughs in clinical practices, we’ll cover key sessions and discussions you won't want to miss. Whether you're attending or unable to make it, this episode ensures you stay at the forefront of diabetes innovation.

Tune in for impactful insights and a glimpse of what's to come at this year’s premier event in Amsterdam.

This podcast was created using AI to provide a quick and insightful summary of the science about to be discussed at ATTD 2025. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. 

ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com  

We’re excited to launch ATTD Conference Catch-Up - a brand-new, AI-powered podcast designed for healthcare professionals who want to stay ahead in diabetes research, technology and treatments.

Whether you’re attending ATTD 2025 in Amsterdam or following from afar, this podcast ensures you don’t miss a thing. Using AI-driven podcast generation, we’ll bring you key takeaways from select sessions, breaking down the latest in diabetes technology, CGM advancements, beta cell therapies, AI applications, and more.

Get ready for insightful summaries!

ATTD 2025 is taking place on March 19-22, 2025, in Amsterdam, the Netherlands. It's the leading event for cutting-edge diabetes research, therapies, and technologies.

Find out more: https://attd.kenes.com/

In this episode of ATTD 2025 Conference Catch-Up, we dive into AI-Driven Healthcare: Opportunities and Challenges, featuring discussions on the transformative potential of AI in diabetes and hypertension management, along with the challenges of integrating machine learning into clinical practice while ensuring patient safety and regulatory compliance.

Join us as we summarize key takeaways from these thought-provoking presentations:

• Artificial Intelligence (AI) for Diabetes Treatment: A Next Step of Systematic Review and Network Meta-Analyses? – Prof. Oliver Schnell
• Data-Driven Machine Learning: Unlocking the Future of Closed-Loop Diabetes Care – Prof. Yao Qin
• Multiomics Biomarkers for Improved Diagnosis of Endocrine Hypertension – Prof. Maria-Christina Zennaro

This episode is an essential listen for endocrinologists, diabetes specialists, data scientists, and healthcare professionals looking to explore the latest advancements in AI and machine learning technologies, and how they are shaping the future of personalized healthcare, diabetes management, and diagnostic accuracy.

Enjoy the listen!

This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.

ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.https://attd.kenes.com

In this episode of ATTD 2025 Conference Catch-Up, we dive into Debate: Adaptive Trials in the Post-Teplizumab Era: To Placebo or Not to Placebo?, featuring a lively discussion on the ethics and necessity of placebo-controlled trials in type 1 diabetes research, with a focus on adaptive trial designs and the future of treatment testing.

Join us as we summarize key takeaways from these thought-provoking presentations:

• Yes, We Should Continue with Placebo – Prof. Colin Dayan
• No, We Should Use Only Active (Approved) Control – Dr. Laura Jacobsen
• Rebuttal by Speaker Presenting the Case for 'Yes' – Prof. Colin Dayan
• Rebuttal by Speaker Presenting the Case for 'No' – Dr. Laura Jacobsen

This episode is an essential listen for researchers, clinicians, and diabetes specialists interested in the future of clinical trial design, the ethical considerations in testing new treatments, and the evolving landscape of type 1 diabetes research.

Enjoy the listen!

This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.

ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com

In this episode of ATTD 2025 Conference Catch-Up, we dive into Updates on Diabetes Management and Female Health, featuring discussions on gender-specific challenges in diabetes care, the role of technology and AI in addressing these disparities, and the need for personalized treatment approaches for women with diabetes.

Join us as we summarize key takeaways from these thought-provoking presentations:

• Leveraging Technology to Address Gender Differences in Diabetes – Prof. Eda Cengiz
• The Role of Estradiol in Energy and Glucose-Insulin Homeostasis – Dr. Lia Bally
• Impact of Sex on the Control of Type 2 Diabetes – Prof. Chiara Fabris
• Sex Differences in Diabetes Management in the Primary Care Setting – Dr. Natalie Bellini
• Sex Differences in Cardiovascular Risk Factors in Youth with Type 1 Diabetes – Dr. Darja Šmigoc Schweiger

This episode is an essential listen for endocrinologists, diabetes specialists, healthcare providers, and researchers who are looking to gain insights into the latest gender-specific approaches in diabetes management and how to leverage technology to improve patient outcomes for women with diabetes.

Enjoy the listen!

This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.

ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.https://attd.kenes.com

In this episode of ATTD 2025 Conference Catch-Up, we dive into Type 2 Diabetes: Empowering Patients with Personalized Treatment, featuring cutting-edge discussions on the role of SGLT2 inhibitors, CGM, and personalized approaches to managing type 2 diabetes and pre-diabetes, with a focus on improving patient outcomes.

Join us as we summarize key takeaways from these thought-provoking presentations:

• SGLT2i Use in Young People Following Approval by FDA and EMA in Type 2 Diabetes – Dr. Lori Laffel
• Do Different Types of Prediabetes Require Different Types of Prevention Approaches? – Dr. Viswanathan Mohan
• Use of CGM in Pre-Type 2 Diabetes – Prof. Viral Shah

This episode is an essential listen for endocrinologists, diabetes care specialists, healthcare providers, and researchers focusing on innovative, patient-centered approaches to managing type 2 diabetes and pre-diabetes, aimed at improving both clinical outcomes and patient experiences.

Enjoy the listen!

This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.

ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.https://attd.kenes.com

In this episode of ATTD 2025 Conference Catch-Up, we dive into Decision Support Technologies – Are They Delivering?, featuring discussions on the effectiveness of AI-driven tools in improving diabetes management, enhancing patient autonomy, and supporting healthcare providers in delivering personalized care.

Join us as we summarize key takeaways from these thought-provoking presentations:

• Decision Support Systems for Healthcare Providers and People with Diabetes – Prof. Revital Nimri
• Spotlight-AQ: Harnessing AI to Deliver the First Step in the Precision Medicine Pathway – Prof. Katharine Barnard-Kelly
• AI Bolus Calculator for People on Multiple Daily Injections – Prof. Anas El Fathi
• Can Decision Support for Evaluating AID Uploads Assist Clinicians? – Prof. Kirsten Nørgaard

This episode is an essential listen for endocrinologists, diabetes specialists, AI innovators, and healthcare providers looking to explore the evolving role of decision support technologies in improving diabetes care, patient outcomes, and clinical efficiency.

Enjoy the listen!

This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.

ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.https://attd.kenes.com

ATTD 2025, the 18thInternational Conference on Advanced Technologies & Treatments forDiabetes, is taking place on March 19-22, 2025, in Amsterdam.

In this episode of ATTD 2025 Conference Catch-Up, we dive into Fully Closed-Loop: A New Era of Control, featuring cutting-edge advancements in machine learning–driveninsulin delivery systems and their potential to transform diabetes management across everyday life, exercise, meals, and clinical settings.

Join us as we summarize key takeaways from these thought-provoking presentations:

• Machine Learning– The Key to Fully Automated Closed-Loop – Prof. Boris Kovatchev
• Meal Compositions and Postprandial Glycemic Management in FullyClosed-Loop Systems – Dr. Laya Ekhlaspour
• Fully Closed-Loop: From Announced to Unannounced Exercise – Prof.Othmar Moser
• Perioperative Closed-Loop Use During Major Surgery – Dr. Lia Bally

This episode is an essential listen for endocrinologists, diabetes specialists, clinicians, and healthcare professionals involved in insulin therapy, looking to stay at the forefront of automated systems and machine learning technologies that are reshaping the future of diabetes management.

Enjoy the listen!

This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.

ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.https://attd.kenes.com

In this episode of ATTD 2025 Conference Catch-Up, we dive into Use of Technology in Pregnancy, featuring innovative discussions on the challenges of managing diabetes during pregnancy, the impact of hybrid closed-loop and insulin delivery systems on glycemic control, and the need for individualized care to optimize outcomes for both mothers and babies.

Join us as we summarize key takeaways from these thought-provoking presentations:

• How Do You Know That Your Pregnant Woman with Diabetes is Well Controlled? – Prof. Yariv Yogev
• Use of the Medtronic 780G Hybrid Closed-Loop System in Type 1 Diabetes Pregnancy – Prof. Katrien Benhalima
• The Role of CamAPS FX in T1D Pregnancy – Prof. Helen Murphy
• Real-World Experience of Hybrid Closed-Loop Use During Type 1 Diabetes Pregnancy: A Spanish Perspective – Dr. Rosa Corcoy

This episode is an essential listen for obstetricians, endocrinologists, diabetes specialists, and healthcare professionals involved in managing pregnant women with diabetes. Learn about the latest advances in diabetes technology and how to apply them for optimal outcomes during pregnancy.

Enjoy the listen!

This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  

ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com 

What’s next in long-acting insulin therapy? Find out in ATTD Diabetes Talks: Long-Acting Insulin Uncovered, a new podcast for healthcare professionals who want to stay ahead in diabetes care.

Hosted by Ginger Vieira and powered by ATTD, this series brings you real conversations with CDCESs, PharmDs, pediatric endocrinologists, and people living with diabetes.

We’ll dive into the latest trends, explore clinical benefits, discuss patient selection strategies, and share real-world success stories to help you apply new insights in your practice.

Subscribe now and join us as we uncover how long-acting insulin is shaping the future of diabetes management.

In the first episode of ATTD’s brand new series on long-acting insulin, join our host Ginger Vieira and guest Jennifer Okemah, RD, CDCES, as they provide an overview of the role of long-acting insulin in diabetes management, the potential benefits, and the evolution of the different formulations available today.

Jennifer Okemah has been a Registered Dietitian (RD)/Nutritionist since 2005 and a Certified Diabetes Care and Education Specialist (CDCES) since 2007.

She has an additional certification as a Sports Specialist in Dietetics as well as being Board Certified in Advanced Diabetes Management.

Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In today’s episode Ginger Vieria is joined by Diana Isaacs, PharmD, and Endocrine Clinical Pharmacist, to dive deeper into the pharmacokinetics and pharmacodynamics of long-acting insulin.

They explore how long-acting insulin can improve blood glucose levels, reduce the burden of daily injections, and simplify insulin management for the person with diabetes.

Diana Isaacs is a diabetes advocate and speaker. She’s a Director in Education & Training in Diabetes Technology at the Cleveland Clinic, and she’s also a Fellow of the Association of Diabetes Care and Education Specialists (FADCES) and the American College of Clinical Pharmacy (FCCP).

If you’d like to dive deeper into today’s topic, don’t miss our CME/CPD accredited e-learning course, titled Breaking New Ground: Once-Weekly Insulin.

The session delves into the evolution of long-acting insulin therapy and introduces groundbreaking once-weekly formulations. 1 CME/CPD Credit available.

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In today’s episode, host Ginger Vieria is joined by pediatric endocrinologist Dr. Ladan Davallow to discuss the factors influencing patient selection.

They explore factors including insulin resistance, lifestyle considerations, and treatment goals, and draw from real-world examples of how clinicians decide on the best candidates for long-acting insulin therapy.

Ladan Davallow, MD is a Pediatric Endocrinologist and Childhood Type 1 Diabetes Consultant & Certified Coach.

She is based in the Medical University of South Carolina Children’s Health Hospital, and is the Co-Founder of and Pediatric Endocrinologist at EndoMD Health, a Virtual Pediatric Endocrine Care Practice.

If you'd like to dive deeper into today’s topic, don’t miss our workshop video: “Patient Selection and Initiation of Long-Acting Insulin Therapy” on the ATTD Education Portal, where Dr. Rodolfo Galindo, Dr. Amit Gupta, Dr. Medha Munshi, Prof. Concetta Irace, and Prof. Raffaella Buzzetti explore two real-world case studies and share expert strategies to guide clinical decisions.

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In today’s episode, host Ginger Vieria is joined by Dr. Egils Bogdanovics to hear perspectives on how to effectively combine long-acting insulin with other diabetes treatments.

They discuss combining long-acting insulin with mealtime insulin, oral medications, and GLP-1 receptor agonists, the role of lifestyle modifications in optimizing insulin effectiveness, and the use of CGM data to refine insulin therapy.

Dr. Egils Bogdanovics is an Assistant Clinical Professor of Medicine at the University of Connecticut. He’s Medical Director at the Charlotte Hungerford Hospital Diabetes Center, and a diplomate of the American Board of Internal Medicine Endocrinology, Diabetes, and Metabolism.

Visit the Insulin Knowledge Hub on the ATTD Education Portal for further resources and in-depth content on long-acting insulin therapy.

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In today’s episode, host Ginger Vieria is joined by Aimée José, RD, CDCES to discuss factors for consideration when initiating, titrating, and monitoring long-acting insulin.

Their conversation provides you with step-by-step guidance on dose titration and adjustments, monitoring and managing adverse effects, and strategies for patient education and engagement during initiation. Aimée draws from her clinical experience working with patients in a non-judgemental manner, encouraging better collaboration between patient and provider.

Aimée José is Principal Clinical Educator at Codex Health. She’s a highly skilled Diabetes Educator with expertise in clinical diabetes care & technology.

Visit the Insulin Knowledge Hub on the Unlok Education website for further resources and in-depth content on long-acting insulin therapy.

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In today’s episode host Ginger Vieira discusses the latest advancements and emerging trends in long-acting insulin therapy with guest Lucia M. Novak, MSN, ANP-BC, BC-ADM.

They cover:

• The latest clinical trials and guidelines

• New insulin formations

• Smart delivery technologies

• The potential of GLP-1 and GIP hormones

• Advice on lowering treatment burden and improving the quality of life for those living with diabetes

Lucia is a board-certified Nurse Practitioner with almost 30 years of clinical expertise in diabetes management. She’s a Consultant, Advisor, National Speaker, Author, Educator, Advocate, and is the President and Founder of Diabesity, LLC.

If you’d like to deepen your knowledge on this topic, why not enroll in the e-Learning course ‘Updates and Emerging Trends in Long-Acting Insulin Therapy’ on the Unlok Education website. Led by esteemed experts Dr. Arthi Thirumalai and Prof. Dr. Eda Cengiz, this session delves into recent clinical trials, updated guidelines, and emerging trends that are shaping the future of diabetes management.

This is an accredited activity that gives you 1 CME/CPD credit.

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In today’s episode, host Ginger Vieira is joined by two patients – one with Type 1 and one with Type 2 diabetes – to share their experiences with long-acting insulin.

They cover:

• Challenges and solutions in real-world insulin therapy

• How personalized strategies improve patient outcomes

• Lessons learned from patient-provider collaborations

• Future opportunities for enhancing patient engagement and adherence

• How to balance diabetes care with lifestyle choices

Christel Oerum is the founder of Diabetes Strong, which provides information about diabetes by people living with the condition. She has lived with Type 1 diabetes since 1997.

Real Prince Blue is a podcast host who has lived with Type 2 diabetes since 2016. A retired cop and army vet, Prince documents his fitness journey on social media. Prince recently finished his doctorate in criminal justice.

Visit the Insulin Knowledge Hub on the ATTD Education Portal for further resources and in-depth content on long-acting insulin therapy.

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In the final episode of our series on Long-Acting Insulin, host Ginger Vieira is joined by David Ahn, MD to answer key questions from fellow clinicians and listeners.

They explore a wide range of topics including:

• General challenges in managing diabetes
• Adjusting insulin doses for better control
• Time in tight range (TITR) and insulin management
• Fasting and diabetes management
• Impact of GLP-1 on Type 1 diabetes management
• Challenges of switching to weekly insulin injections
• Defining and managing hypoglycemia risk
• Personalized diabetes management approaches
• Diabetes management in athletes

Dr David Ahn is Program Director and Kris V. Iyer Endowed Chair in Diabetes Care at the Mary and Dick Allen Diabetes Center in Newport Beach, CA. Dr Ahn is a leading digital health speaker, writer, and innovator, and currently serves as the Technology Blog Editor for the nonprofit organization, Taking Control of Your Diabetes.

Visit the Insulin Knowledge Hub on the ATTD Education Portal for further resources and in-depth content on long-acting insulin therapy.

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In the first episode of our new series CGM in Focus, supported by Dexcom, host Dr David Kerr takes a closer look at AI-Driven CGM, its impact on the latest technology in continuous glucose monitoring, and what it means in practice for clinicians and patients alike.

To discuss this exciting topic, Dr Kerr is joined by Consultant Physician in Metabolic Medicine, Dr Shivani Misra.

They cover:

• The Role of AI in Continuous Glucose Monitoring

• Challenges and Potential of AI in Diabetes Management

• AI and CGM for Young People with Diabetes

• Potential for AI to instigate behaviour change

Dr Shivani Misra is a Consultant Physician in Metabolic Medicine, a Wellcome Trust-funded investigator, and Head of Metabolic Medicine at Imperial College London. Dr Misra specialises in early-onset type 2 diabetes, atypical and non-classical diabetes phenotypes, and congenital hyperinsulinism.

Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode, Dr David Kerr continues his look at AI-driven CGM tools and the future of diabetes and metabolic health. He’s joined by Stanford W. Ascherman Professor of Genetics, Dr Michael Snyder to hear the latest on emerging technologies, and the shift towards integrative and personalised healthcare.

They discuss:

• How AI and CGM technology is transforming diabetes and metabolic health management

• AI identification of diabetes subtypes and personalised interventions

• Impact of physical activity, sleep, and stress on glucose levels, as well as the emerging role of gut microbiome health in metabolic wellness

• Potential of AI-driven tools for early intervention and improved health outcomes

Dr Snyder is the Stanford W. Ascherman Professor of Genetics and Director at the Stanford Center of Genomics and Personalized Medicine. He is a leader in the field of functional genomics and proteomics, and co-founder of many biotechnology companies, including Personalis, SensOmics, Qbio @qbioinc, January AI, Filtricine, Mirvie, and Protos.

Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode, Ginger Vieira looks at the latest technology in CGM and what it means for diabetes care during pregnancy.

She is joined by Dr Denice Feig to discuss the latest research and trends in CGM during pregnancy.

They discuss:

• How CGM improves maternal and neonatal outcomes

• Key clinical trials including the CONCEPTT trial

• Evolving trends in CGM use across different types of diabetes in pregnancy (T1D, T2D, GDM)

Dr Denice Feig is a Professor of Medicine in the Division of Endocrinology and Metabolism at the University of Toronto. She is a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute and an Adjunct Scientist at ICES. Dr Feig is also the Head of Diabetes and Endocrinology in the Pregnancy Program at Mount Sinai Hospital.

Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode, Ginger Vieira explores the common pitfalls of CGM use in pregnancy with Dr Sarit Polsky.

They discuss:

• Common barriers to successful CGM use in pregnancy, including skin issues and alarm fatigue
• Practical troubleshooting strategies for clinicians and patients

• The role of education and support in overcoming CGM-related challenges

Sarit Polsky is an Associate Professor of Medicine and Pediatrics at the University of Colorado, where she is the Director of the Pregnancy and Women’s Health Clinic. She is the Research Director of the Adult Clinic at the Barbara Davis Center for Diabetes and the co-Director of the American College of Diabetology Annual Conference.

Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode, Ginger Vieira looks at postpartum CGM management, diabetes risk, and what clinicians can do to support women during this significant life event.

She is joined by Dr Grenye O’Malley.

They discuss:

• How glucose patterns and insulin needs change postpartum

• GDM as a spectrum to Type 2 diabetes

• CGM use for early detection of type 2 diabetes after GDM

• Strategies for transitioning from intensive pregnancy care to postpartum follow-up

Grenye O'Malley is an Associate Professor in the Division of Endocrinology, Diabetes and Bone Diseases at the Icahn School of Medicine at Mount Sinai. She has research interests in the use of diabetes technologies focusing on health disparities and management of diabetes during pregnancy.

Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In the final episode of our series on CGM technology, Ginger Vieira explores the future directions for CGM in high-risk pregnancy care with Dr Claire Meek.

They discuss:

• High-Risk Pregnancies and Current Gaps in Care

• Challenges in Type 2 Diabetes Research

• Impact of CGM Technology During Pregnancy

• Pre-Pregnancy and Pregnancy Care for Type 2 Diabetes

• Third Trimester and Delivery Considerations

• Early Adoption of Hybrid Closed Loops

Dr Claire Meek is a Professor of Chemical Pathology & Diabetes in Pregnancy at the University of Leicester in the UK. She’s also an Honorary Consultant Chemical Pathologist & Metabolic Physician at the Addenbrooke’s Hospital.

Explore more on the ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

Diabetes technology is evolving fast. In ATTD Tech Connect, we show how it can help healthcare professionals — nurses, educators, and dieticians — improve therapy and daily life for people living with diabetes.

In this new series sponsored by Medtronic Diabetes, you’ll learn from diverse clinical experience and evidence-based guidance from leaders in diabetes care, tailored for those who support patients every day.

Hosted by Julie Taplin, Dietician and Medtronic Diabetes Education Specialist, the series will explore practical strategies to reduce burden, support meal planning and exercise, and optimize outcomes in real-world care.

Make sure you’re subscribed to the ATTD Podcast feed today.

Explore further resources:

• ATTD Education Portal. Register now to access exclusive content and stay ahead in the field!
• Minimed Medtronic Academy and WePartner Online

How can diabetes educators be supported in the fast-moving world of diabetes technology?

In the first episode of ATTD Tech Connect, host Julie Taplin discusses the need for an educational pathway for diabetes educators when training PwD on the MiniMed™ 780G system with Geraldine Gallen.

They discuss:

• Why the pathway is needed

• The four key components of the pathway

• The barriers to providing diabetes educator training

• Implementing the pathway at King’s College Hospital

Geraldine Gallen is a Type 1 Service Lead and Diabetes Nurse Consultant at Kings College Hospital, London. She is UK​ and Vice Chair of the Association of British Clinical Diabetologists (ABCD) – Diabetes Technology Network (DTN), UK​. 

This series is sponsored by Medtronic Diabetes.

Explore further resources:

• ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.

• Minimed Medtronic Academy and WePartner Online

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode of ATTD Tech Connect, host Julie Taplin and her guests explore how healthcare professionals can make the most of CareLink™ Clinic - a powerful tool for supporting healthcare professionals and people living with Type 1 diabetes.

They discuss:

• An overview of the CareLink™ Clinic reports

• The three-Step Methodology for Healthcare Professionals

• Using CareLink™ Clinic reports for Patient Education

• Dietary Insights and CareLink™ Clinic 

Douha Almajaly is a Diabetes Educator, and Maheen Ahmed is a Clinical Dietician, both from Sidra Medicine. Professor Goran Petrovski is the Medical Director for Medtronic Diabetes and an Endocrinologist & Diabetologist working at Sidra Medicine.

This series is sponsored by Medtronic Diabetes.

Explore further resources:

• ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.

• WePartner Online and Medtronic Diabetes Academy

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode of ATTD Tech Connect, host Julie Taplin and her guest, Maya Laron Hirsh, Clinical Dietician, discuss managing meals with the MiniMed™ 780G system.

They discuss:

• Carb counting

• What to do if you miss a bolus

• How to handle high fat and/or protein meals

Maya Laron Hirsh is a Clinical Dietician, Head of Diabetes & Obesity Nutrition Department at Sheba Medical Center, and Chair of the Diabetes Forum, Israeli Dietetic Association. She specializes in nutritional therapy for automated insulin delivery systems and has worked closely with people with diabetes using the 780G system.

This series is sponsored by Medtronic Diabetes.

Explore further resources:

• ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.

• WePartner Online and Medtronic Diabetes Academy

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode of ATTD Tech Connect, host Julie Taplin and her guest, Ashley Mehnert, Diabetes Clinical Nurse Specialist, break down the Smart MDI system and its benefits.

They discuss:

• What exactly is Smart MDI system

• How it differentiates from standard MDI therapy

• Benefits, including visibility to insulin use

• The actionable alerts and clinical impact

Ashley Mehnert is a Diabetes Clinical Nurse Specialist working in the NHS in the north east of England.

This series is sponsored by Medtronic Diabetes.

Explore further resources:

• ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.

• WePartner Online and Medtronic Diabetes Academy

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode of ATTD Tech Connect, host Julie Taplin and Amy Jolley, Lead Diabetes Specialist Dietician, discuss exercise management in diabetes and the ways the MiniMed™ 780G system supports people with diabetes and healthcare professionals.

They discuss:

• Barriers to exercise for people living with diabetes

• The different glucose responses to aerobic and anaerobic exercise 

• The features and benefits of AID systems compared with MDI therapy 

• Advice on bolusing, fuelling during exercise, pre and post meal suggestions and ways to help reduce hypos

Amy Jolley is a Lead Diabetes Specialist Dietician for the young adult and transition services at Salford Care Organisation, NHS, in the UK.

This series is sponsored by Medtronic Diabetes.

Explore further resources:

• ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.

• WePartner Online and Medtronic Diabetes Academy

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode of ATTD Tech Connect, host Julie Taplin and Professors Tadej Battelino and Klemen Dovč discuss the importance of multi-disciplinary diabetes care, and offer solutions to the common challenges that can crop up when managing a diabetes team.

They discuss:

• Common challenges such as time constraints, busy clinics, and comorbidities

• Solutions such as effective communication, regular meetings, and the use of AI in automating workloads

• Importance of synergy across various departments and professions within diabetes care

Professor Tadej Battelino is Co-Chair of ATTD and Chair of the International Diabetes Federation Europe. Professor Klemen Dovč is an Associate professor in the Faculty of Medicine at the University of Ljubljana.

This series is sponsored by Medtronic Diabetes.

Explore further resources:

• ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.

• WePartner Online and Medtronic Diabetes Academy

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode of ATTD Tech Connect, host Julie Taplin and Professor Katarzyna Cyranka, clinical psychologist and psychotherapist, discuss the important topic of burden and quality of life related to diabetes and diabetes technologies for people living with diabetes.

They discuss:

• Distinguishing diabetes distress from diabetes burnout

• Possible sources of diabetes distress

• The role of diabetes technology, especially AHCL, in reducing diabetes distress

• Signs to watch out for as clinicians, nurses, and educators

• Tools to assist in naming and identifying sources of diabetes distress

Professor Katarzyna Cyranka is a clinical psychologist and certified psychotherapist, based in Krakow, Poland. 

This series is sponsored by Medtronic Diabetes.

Explore further resources:

• ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.

• WePartner Online and Medtronic Diabetes Academy

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode of ATTD Tech Connect, host Julie Taplin and Dr Anna Korsgaard Berg discuss skin care management for people living with diabetes using diabetes technology.

They discuss:

• The different skin layers and how they can be impacted by the use of diabetes technology

• How poor skin integrity directly affects glucose outcomes

• Things to look out for and ask as a clinician

• Some practical prevention strategies

• Latest research on using ultrasounds to measure skin depth

Dr Anna Korsgaard Berg is a Diabetes researcher at Steno Diabetes Center, Copenhagen and works in Pediatrics at Herlev Hospital.

This series is sponsored by Medtronic Diabetes.

Explore further resources:

• ATTD Education Portal. Register now to access exclusive content and stay ahead in the field.

• WePartner Online and Medtronic Diabetes Academy

Make sure you’re subscribed to the ATTD Podcast feed today. Leave us a review and share with a colleague.

In this episode of ATTD 2026 Conference Catch-Up, we dive into The Use of Technology in Treating Type 2 Diabetes, featuring cutting-edge insights into how technological advancements are transforming diabetes management. 

Join us as we summarize key takeaways from these thought-provoking presentations: 

• Using Apps to Support Management of Type 2 Diabetes — Prof. Julia Mader 

• Connected Pens in Type 2 Diabetes — Prof. Concetta Irace 

• CGM in Type 2 Diabetes — Dr. J. Hans DeVries 

• Automated Insulin Delivery in Type 2 Diabetes — Prof. Yves Reznik 

This episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals seeking to stay ahead of the curve on the integration of technology into Type 2 diabetes treatment. Get the latest on how apps, connected devices, CGM, and automated insulin delivery systems are shaping modern care. 

Enjoy the listen! 

This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. 

ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com